The highly anticipated rollout of a COVID-19 vaccine poses ethical considerations: When will trial volunteers who got a placebo be vaccinated? And how will this affect the data in those trials?

Las Vegas’ long-vacant Moulin Rouge gaming property may soon again be the site of a gambling venue. Before its demise, it was once the sole desegregated, upscale casino in Southern Nevada.

With COVID-19 rates spiking in November, and talks of more shutdowns happening in December, the world is impatiently waiting for a safe and effective COVID-19 vaccine.

With COVID-19 rates spiking in November, and talks of more shutdowns happening in December, the world is impatiently waiting for a safe and effective COVID-19 vaccine.

The ongoing coronavirus pandemic has done nothing to quell the upward trajectory of home prices in Southern Nevada.

The goal is clear: To reduce statewide greenhouse gas emissions to net-zero by 2050.

The Southern Nevada Health District (SNHD) is preparing to roll out a vaccination campaign once the Pfizer and Moderna vaccines are approved.

I suppose this is progress: On Sunday, Trump’s vaccine “czar,” Moncef Slaoui, endorsed President-elect Biden’s plan to ask all Americans to wear masks during his first 100 days. Slaoui’s said, “I think it’s a good idea…We all need to take our precaution, have our masks…We will not all have the vaccine in our arms before May or June. So we need to be very cautious and vigilant.”